DIRS.INFO The most relevant business & tech news

☆ 7 times a total solar eclipse revolutionized science
▼ + stars: | 2024-04-06 | by ( Jenny Mcgrath | ) www.businessinsider.com time to read: +8 min

In the middle of the afternoon, day will shift to night, as a total solar eclipse touches 15 states. We know now what causes a total solar eclipse. Here are seven times a total solar eclipse has helped advance human science. Culture Club/Bridgeman via Getty ImagesOn March 14, 189 BCE, a total solar eclipse swept over what is now northern Turkey. Corbis via Getty ImagesGemini 12 astronauts Jim Lovell and Buzz Aldrin were the first humans to see a total eclipse from space.

Persons: —, China's emporer, Edmond Halley, De, Anaxagoras, Hipparchus, Nicaea, Edmond, Halley, Isaac Newton's, Norman Lockyer, Pierre Jules César Janssen, Janssen, Lockyer, James Craig Watson, Vulcan, Albert Einstein, Einstein, Corbis, Jim Lovell, Buzz Aldrin Organizations: Service, Business, Getty, Alexandria . Culture Club, Bridgeman, Science, Society Picture Library, Sun, Mercury, Wallops, Smithsonian Magazine, NASA Locations: Ireland, China, Alexandria, Turkey, Egypt, England, India, French, Guntur, Brazil, Principe, Africa, Virginia, Peru

☆ Dutch man confirmed as world’s longest-living heart transplant recipient
▼ + stars: | 2024-03-04 | by ( Story Reuters | ) edition.cnn.com time to read: +2 min

He says he is proof that living a long time with a heart transplant is possible. In 1984, the Netherlands had yet to perform its first heart transplant, so cardiologist Albert Mattart referred the teenager to Harefield Hospital in England. Janssen underwent transplant surgery in June that year after a heart became available following a tragic car crash in which two young adults died. The average life expectancy for heart patients after a transplant is 16 years, according to Janssen’s current cardiologist, Casper Eurlings. Transplant patients “need to maintain a healthy lifestyle and be active.

Persons: Bert Janssen, ”, Albert Mattart, Janssen, Piroschka Van De Wouw, Magdi, “, “ I’ve, Casper Eurlings, Harold Sokyrka, ” Eurlings, Yacoub, ” Janssen Organizations: Reuters, Harefield Hospital, Guinness World Records, Guinness . Transplant Locations: Netherlands, England

☆ This startup is opening a mental health clinic that offers ketamine therapy. We got an exclusive look at the pitch deck it used to raise $5.4 million.
▼ + stars: | 2024-01-25 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

Read previewVenture investment in mental health startups exploded in 2021. Being Health, an integrated mental healthcare company, is opening its first location, located in Manhattan's Financial District. Services like ketamine infusions and acupuncture will have to be administered in person, but others, like nutrition counseling, will have a virtual option, Sharma said. "When it comes to this novel approach to addressing mental health, you can't do that with telehealth." See the 17-slide pitch deck mental health startup Being Health used to raise $5.4 million in seed funding.

Persons: —, Allie Sharma's, Sharma, Janssen, Haim Dabah, Dabah Organizations: Service, Business, Financial, HDS, FDA, Janssen Pharmaceuticals, Being Health, Services, HDS Capital Locations: New York, New York City

☆ Ukraine: Exhausted and disappointed with allies, President Zelensky and military chief warn of long attritional war
▼ + stars: | 2023-11-03 | by ( Analysis Tim Lister | ) edition.cnn.com time to read: +10 min

CNN —Two articles published this week give a stark assessment of Ukraine’s prospects in its war with Russia. One – by the commander in chief of the Ukrainian military – admits the battlefield has reached a stalemate and a long attritional war benefiting Moscow beckons. The other portrays Ukrainian President Volodymyr Zelensky as exhausted by the constant effort to cajole and persuade allies to keep the faith. Commander-in-Chief of the Armed Forces of Ukraine Valery Zaluzhny during an event dedicated to Ukraine's Independence Day on August 24, 2023 in Kyiv, Ukraine. Shuster quotes an aide to the Ukrainian president as saying Zelensky feels “betrayed by his Western allies.

Persons: –, Volodymyr Zelensky, Valery Zaluzhny, TIME’s Simon Shuster, Zelensky, “, ” Shuster, Ukraine Valery Zaluzhny, Yan Dobronosov, …, Zaluzhny, Rustem Umerov, ”, Bram Janssen, ” Zaluzhny, Dmitri Peskov, Biden, Sen, J.D, Vance, ” Zelensky, Shuster, Vladimir Putin’s Organizations: CNN, Armed Forces, Ukrainian Defense, Defense Lines, “, ”, Gallup, Capitol, Republican Locations: Russia, Moscow, United States, Europe, Ukraine, Kyiv, USSR, East, Avdviika, Vuhledar, Donetsk, Kupyansk, Kharkiv, Crimea, –, Izyum, “ Russia, ” Moscow, Israel, Washington, Kherson

☆ Bladder cancer studies suggest new ways to treat the disease and improve survival
▼ + stars: | 2023-10-22 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +9 min

This is one of several new studies exploring ways to improve how bladder cancer is treated. “Ever since I was in med school, a metastatic bladder cancer treatment was gemcitabine and platinum. Urothelial cancer is a type of bladder cancer that begins in the urothelial cells, which line the inside of the bladder. The drug became the first therapy targeting a genetic alteration to be approved by the FDA to treat patients with the most common type of bladder cancer, metastatic urothelial cancer. “These results support nivolumab plus cisplatin-based chemo as a new standard approach for the treatment of metastatic urothelial cancer.”

Persons: vedotin, hadn’t, ”, Thomas Powles, ” Powles, we’ve, —, Powles, Toni Choueiri, Dana, “, enfortumab, ” Choueiri, drugmaker Janssen, Dr, Sanjay Gupta, nivolumab, Matthew Galsky Organizations: CNN, Society for Medical Oncology, University of London, Barts Cancer, US, Inc, Astellas Pharma, Merck, Co, Food and Drug Administration, FDA, EMA, Lank, Genitourinary Oncology, Farber Cancer Institute, ESMO, New England, of Medicine, University of Texas, Anderson Cancer Center, US Food and Drug Administration, National Library of Medicine, CNN Health, Bristol Myers Squibb, Ono Pharmaceutical Company, Cancer, The Tisch Cancer Institute Locations: Madrid, United Kingdom, United States, Europe, Mount Sinai

☆ First Pill for Dengue Shows Promise in Human Challenge Trial
▼ + stars: | 2023-10-20 | by ( Oct. | At A.M. | ) www.usnews.com time to read: +3 min

By Jennifer Rigby(Reuters) - A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday. In human challenge trials, researchers intentionally expose healthy volunteers to a pathogen to test a vaccine or treatment, or better understand the disease they cause. Dengue fever, while often asymptomatic, is also known as “break bone fever” for the severity of the joint pain and spasms that some patients experience. In the trial done with Johns Hopkins Bloomberg School of Public Health, 10 volunteers were given a high dose of the J&J pill five days before being injected with a type of dengue. The five people in a placebo group, who were also injected with dengue, all showed detectable virus when tested.

Persons: Jennifer Rigby, Johnson, Van Loock, J’s Janssen, Jeremy Farrar, Johns, J, “, ”, Bill Berkrot Organizations: Reuters, Johnson, American Society of Tropical Medicine, Hygiene, J, Health Organization’s, Johns Hopkins Bloomberg School of Public Health, WHO Locations: United States, Chicago, Asia, Latin America

☆ Chiamaka Nnadozie: Her father didn’t want her to play soccer. Nigerian star defied him and rewrote the record books
▼ + stars: | 2023-10-20 | by ( Michael Johnston | Amanda Davies | ) edition.cnn.com time to read: +7 min

It’s been a long, winding road from a small semi-urban town in Nigeria to the World Cup knockout stages. Cathrin Mueller/Getty Images Europe/Getty Images‘I was crying’The Nigerian goalkeeper rose to stardom after becoming the youngest-ever goalkeeper to keep a clean sheet at a Women’s World Cup back in the 2019. Only 19 years old at the time, Nnadozie played three games in France, showcasing confidence and authority on a level more commonly associated with seasoned professionals. Nnadozie saves a penalty against Christine Sinclair of Canada at the FIFA Women's World Cup. “When I saw the post, for me, I think she made a good point.”Nnadozie catches a cross while being challenged by France's Kadidiatou Diani at the 2019 Women's World Cup.

Persons: Chiamaka, –, CNN’s Amanda Davies, Nnadozie, It’s, Cathrin Mueller, ” Nnadozie, ’, Randy Waldrum’s, Christine Sinclair, Sinclair, parrying, Morgan Hancock, Alessia Russo, Frida Manuum, Wolfsburg’s Dominique Janssen, ”, ‘, Mary Earps, Chile’s Christiane Endler, France's Kadidiatou Diani, Stephane Mahe, “ Organizations: CNN, Paris FC, Nigeria, World, UEFA Women's, League, VfL Wolfsburg, Getty, ’ ” Nigeria, FIFA, England, Canada, Super Falcons, Women’s Champions League, Arsenal, Paris, Wolfsburg, Women’s, Reuters Locations: Nigeria, Wolfsburg, Germany, Europe, France, Australia, Canada, Randy Waldrum’s Nigeria, Jordan, Nnadozie, England

That adds to tech-related tensions between the West and China, which is one of Europe’s biggest trading partners and the world’s biggest auto market. Chinese EV makers are drawn to Europe because auto import tariffs are just 10% versus 27.5% in the U.S., independent auto analyst Matthias Schmidt said. MG — owned by SAIC Motor, China’s biggest automaker — is the largest Chinese EV player in Europe. One reason Chinese companies can offer high-quality cars at affordable prices stems from the rules to enter the Chinese market. Chinese EV makers, meanwhile, are trying to stand out in a crowded field.

Persons: Laima Springe, Janssen, “, ” Springe, I’m, ”, Matthias Schmidt, John Kirkwood, —, Kirkwood, Warren Buffett, Ursula von der Leyen, Alfa, China’s EVs, Carlos Tavares, we’re, Alexander Klose, ” Klose, Schmidt, Justin Nicholls, Nicholls Organizations: Volvo, Nissan, Skoda, Union, EV, Volkswagen Passat, Kia, MG, SAIC Motor, China’s, —, Lotus, Chinese Commerce Ministry, EU, World Trade Organization, Tesla’s, Peugeot, Citroen, Alfa Romeo, Fiat, Global, Wall Motors Locations: Copenhagen, Denmark, Europe, China, West, U.S, British, Western, France, Germany, Beijing, Shenyang, Shanghai, Israel

☆ Drugmakers opt in to Medicare drug price negotiations – here's what happens next
▼ + stars: | 2023-10-02 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, even after many of them sued to halt the process last month. The Centers for Medicare & Medicaid Services did not immediately respond to a request to confirm that all drugmakers agreed to the talks. President Joe Biden's Inflation Reduction Act, which passed last year, empowered Medicare to negotiate drug prices for the first time in the program's six-decade history. The pharmaceutical industry also argues that the process will threaten revenue growth, profits and drug innovation.

Persons: Joe Biden's, Boehringer Ingelheim, Johnson Januvia, Merck Farxiga, Novartis Enbrel, Amgen Imbruvica, AbbVie Stelara, Janssen, Bristol Myers, Biden Organizations: Pfizer Pharmaceuticals, CNBC, Medicare, Services, Sunday, Bristol Myers Squibb Jardiance, Johnson, Merck, AstraZeneca Entresto, Novartis, Novo Nordisk, U.S, CMS, Bristol, Bristol Myers Squibb Locations: Provo , Utah

CAPE TOWN, South Africa (AP) — U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug, the country's antitrust regulator said Friday. It is desperately-needed by South Africa, where the infectious disease is the leading cause of death, killing more than 50,000 people in 2021. South Africa has more than 7 million people living with HIV, more than any other country in the world. The group says the contracts show J&J charged South Africa 15% more per vaccine dose than it charged the much richer European Union. Pfizer charged South Africa more than 30% more per vaccine than it charged the African Union, even as South Africa struggled to acquire doses while having more COVID-19 infections than anywhere else on the continent.

Persons: Johnson, Bedaquiline, Janssen, Norbert Ndjeka, Ndjeka, Intiative, J Organizations: —, Johnson, J's, Janssen Pharmaceuticals, South Africa's, World Health Organization, WHO, Global, J, bedaquiline, Commission, Pfizer, Health, Union, African Union, Initiative, ___ AP Locations: CAPE, South Africa, J's Belgium, Africa, Africa's, ___, africa

Johnson & Johnson is signing off on a new logo. Johnson & Johnson itself narrowed its focus to pharmaceuticals and medical devices. The signature logo was “one of the longest-used company emblems in the world,” J&J declared in a 2017 website post. “Everyone washed their baby with Johnson & Johnson baby shampoo,” she said. New Brunswick, New Jersey-based J&J also will rename its Janssen pharmaceutical segment, changing it to Johnson & Johnson Innovative Medicine.

Persons: Johnson, James Wood, ”, Vanessa Broadhurst, ” J, J, Laura Ries, Ries, wasn't Organizations: Janssen, Johnson Innovative Medicine, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: New Brunswick , New Jersey

☆ IBM notifies J&J unit Janssen CarePath's customers of unauthorized data access
▼ + stars: | 2023-09-06 | by ( ) www.reuters.com time to read: +1 min

REUTERS/Nacho Doce/File Photo Acquire Licensing RightsSept 6 (Reuters) - IBM (IBM.N) said on Wednesday it is notifying customers of Janssen CarePath, a Johnson & Johnson (JNJ.N) unit, of a "data incident" involving unauthorized access of personal information. The personal information was part of a database used on the Janssen CarePath platform, according to IBM. IBM, which manages the database, said it was unable to determine the extent of the unauthorized access. Janssen CarePath offers resources to patients who have been prescribed J&J's medication by helping them understand insurance coverage and out-of-pocket costs. The "data incident" may have included individuals' names and information such as contact details and information related to health insurance and medications that were provided to the Janssen CarePath application, IBM said.

Persons: Nacho, Janssen CarePath, Johnson, Janssen, Jaspreet Singh Organizations: Business Machines Corporation, IBM, Congress, REUTERS, Social, Janssen CarePath, Thomson Locations: Barcelona, Spain, Bengaluru

☆ Putin and Kim Jong Un have been trading letters as secret talks on getting North Korean weapons into Russia's hands are 'actively advancing,' White House says
▼ + stars: | 2023-08-30 | by ( Jake Epstein | ) www.businessinsider.com time to read: +7 min

Arms negotiations between Russia and North Korea are "advancing," a White House official said. Several months later, the White House disclosed that Russia had gone as far as to offer food to impoverished North Korea in exchange for military aid. He asserted that the US will take action by sanctioning individuals and entities "working to facilitate arms deals between these two countries." The Biden administration's new warning about Russia's quest for military support on Wednesday comes as Ukrainian forces continue to make slow and steady territorial gains amid their grueling counteroffensive in the eastern and southern regions. Despite criticism and concerns from some in the West about Ukraine's progress, Washington and its NATO allies have asserted their commitment to providing Kyiv with military support.

Persons: Putin, Kim Jong Un, Sergei Shoigu, Vladimir Putin, Kim Jong, John Kirby, Shoigu's, Kirby, Biden, Washington, We're, Bram Janssen, Janet Yellen Organizations: White, Service, Russia, Defense, Artillery, North, National Security, DPRK, Democratic People's, Russia's, Russian, Korean Central News Agency, KCNA, REUTERS, US, Wagner Group, Kremlin, White House, United Nations, AP, US Treasury Department, Slovakian, NATO, Pentagon Locations: Russia, North Korea, Wall, Silicon, Russia North Korea, Moscow, Ukraine, Russian, Pyongyang, North Korean, Korea, Democratic People's Republic of Korea, Iran, DPRK, Washington

☆ Biden administration unveils first 10 drugs subject to Medicare price negotiations
▼ + stars: | 2023-08-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +7 min

Fiasp and NovoLog, insulins made by Novo Nordisk The Medicare negotiations are the centerpiece of the Biden administration's efforts to rein in the rising cost of medications in the U.S. Drugmakers such as Merck and Johnson & Johnson and their supporters aim to derail the negotiations, filing at least eight lawsuits in recent months seeking to declare the policy unconstitutional. Drugmakers' legal challengesMerck, Johnson & Johnson, Bristol-Myers Squibb and Astellas Pharma are among the companies suing to halt the negotiation process. The suits make similar and overlapping claims that Medicare negotiations are unconstitutional. Biden and his top health officials have embraced the lawsuits as evidence that they're making progress in the fight to cut drug prices.

Persons: Biden, Joe Biden's, Boehringer Ingelheim, Johnson Januvia, Merck Farxiga, Novartis Enbrel, Amgen Imbruvica, AbbVie Stelara, Janssen, insulins, Johnson, Leigh Purvis, Drugmakers, drugmakers, Robert Davis Organizations: Bristol, Myers Squibb Jardiance, Johnson, Merck, AstraZeneca Entresto, Novartis, Novo Nordisk, Medicare, Centers, Services, Biden, AARP Public, Institute, Congressional, Office, Myers Squibb, Astellas Pharma, U.S . Chamber, Commerce, Supreme, Court, Circuit Court, Pharma, White, Big Pharma Locations: U.S, Bristol

☆ J&J's Janssen to close part of its vaccine division
▼ + stars: | 2023-08-23 | by ( ) www.cnbc.com time to read: 1 min

Johnson & Johnson Covid-19 vaccines are seen on a table in Los Angeles, May 7, 2021. Johnson & Johnson 's Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported. In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programs, which it said it had initially disclosed in its 2023 second-quarter results. "We also continually assess our global footprint, including in the Netherlands, to ensure it meets our current and evolving scientific needs," Johnson & Johnson said. De Telegraaf reported that 2,500 people worked at Janssen in the Netherlands, a quarter of which were in the section specialising in infectious diseases and vaccines.

Persons: Johnson, Johnson Covid, Janssen, De Telegraaf Locations: Los Angeles, Netherlands

☆ J&J's Janssen to close part of its vaccine division -Telegraaf
▼ + stars: | 2023-08-23 | by ( ) www.reuters.com time to read: +2 min

[1/2] The exterior of Johnson and Johnson's subsidiary Janssen Vaccines in Leiden, Netherlands, March 9, 2021. REUTERS/Piroschka van de Wouw Acquire Licensing RightsAMSTERDAM, Aug 23 (Reuters) - Johnson & Johnson's (JNJ.N) Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and development operations in the Netherlands, newspaper De Telegraaf reported. In an emailed response on Wednesday, Johnson & Johnson confirmed plans to exit some of its vaccine research and development programmes, which it said it had initially disclosed in its 2023 second-quarter results. De Telegraaf reported that 2,500 people worked at Janssen in the Netherlands, a quarter of which were in the section specialising in infectious diseases and vaccines. J&J's relatively large Dutch vaccine operation stems in part from its $2.1 billion acquisition in 2011 of vaccine maker Crucell.

Persons: Johnson, de Wouw, Janssen, De Telegraaf, J, Charlotte Van Campenhout, Toby Sterling, David Goodman, David Evans Organizations: Janssen Vaccines, REUTERS, Rights, Thomson Locations: Leiden, Netherlands

☆ Clinical data is a goldmine — but Europe's startups are struggling to grow
▼ + stars: | 2023-08-14 | by ( Riddhi Kanetkar | ) www.businessinsider.com time to read: +5 min

Big Pharma and biotech companies often outsource clinical trials to external companies. Europe's early-stage clinical trials startups are flush with funds but they're struggling to grow. The fate — and market cap — of a biotech company often lies with a successful clinical trial. The COVID-19 pandemic also spotlighted another promising alternative to carry out these trials — startups. While the US touts around a dozen clinical trials unicorns valued at $1 billion or higher, per Dealroom estimates, Europe's startups are lagging behind.

Persons: BEN, Janssen, Christoph Ruedig, Maya Zlatanova, Europe hasn't, Matt Wilson, Wilson, Christoph Massner, it's, Ruedig Organizations: Big Pharma, pharma, Janssen Pharmaceuticals, Tempus, Venture, Albion VC, US, Earlybird Ventures Locations: Europe, New York, American

☆ Investor Sarat Sethi says don’t chase this rally, but you can buy these safe stocks
▼ + stars: | 2023-08-10 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Chasing the market higher is a bad idea right now, and investors should turn to safe-haven sectors instead, investor Sarat Sethi warned. "I think as an equity investor, one needs to be really careful here and not chase some of these rallies, especially for stocks that are looking for lower discount rates." Stocks rose on the back of the data, with the Dow Jones Industrial Average trading more than 400 points higher at its session peak. Haleon and pharmaceutical giant Johnson & Johnson were also mentioned by Sethi. Johnson & Johnson is down 2% in 2023 but has risen more than 3% in August.

Persons: Sarat Sethi, Sethi, Dow Jones, Freeport's, Johnson Organizations: Reserve, Dow Jones Industrial, Johnson, GSK, Janssen Pharmaceuticals, Food and Drug Administration Locations: Freeport, McMoRan

☆ Dunedin delight as Dutch put seven past Vietnam to top group
▼ + stars: | 2023-08-01 | by ( ) www.reuters.com time to read: +3 min

Roord drew a fantastic save from Kim Thanh just before halftime, but Van de Donk was on hand to tap in the rebound. After Brugts' superb sixth with another fierce strike, Roord, who had hit the crossbar, headed in the seventh with seven minutes remaining. "I was afraid that the gap would be even bigger," Vietnam coach Mai Duc Chung said. "We have tried our best but it is clear that we cannot close the gap between us and the Netherlands. Reporting by Hritika Sharma in Hyderabad, editing by Nick Mulvenney and Christian RadnedgeOur Standards: The Thomson Reuters Trust Principles.

Persons: Danielle van de Donk, Jill Roord, Sherida Spitse, Molly Darlington, Esmee Brugts, Brugts, Vivianne Miedema, Lieke Martens, Katja Snoeijs, Dominique Janssen, Martens, Tran Thi Kim Thanh, Snoeijs, Van de Donk, Roord, Kim Thanh, Mai Duc Chung, Hritika Sharma, Nick Mulvenney Organizations: Soccer Football, FIFA, Forsyth Barr, Sherida Spitse REUTERS, Vietnam, Portugal, Sweden, Thomson Locations: New Zealand, Vietnam, Netherlands, Dunedin , New Zealand, Molly Darlington DUNEDIN , New Zealand, United States, Auckland, Sydney, Italy, Vietnam's, Roord, Janssen's, Hyderabad

☆ Champions United States held 1-1 by Dutch in World Cup thriller
▼ + stars: | 2023-07-27 | by ( Amy Tennery | ) www.reuters.com time to read: +3 min

The Dutch struck first through a fine shot from midfielder Jill Roord in the 17th minute and the U.S. went in at halftime trailing in a World Cup match for the first time since 2011. The Americans had not drawn a World Cup match since 2015 and will rue a slow start to the game as well as an inability to take their chances at the end. "What you saw in the second half is what you're going to see going forward as a baseline." But after the second half, that's what we wanted because the U.S. were really strong." Reporting by Amy Tennery in Wellington, editing by Nick MulvenneyOur Standards: The Thomson Reuters Trust Principles.

Persons: Yoshimi Yamashita, Lindsey Horan, Danielle van de Donk, Amanda, Read, Jill Roord, Horan, Rose Lavelle, Daphne van Domselaar, Vlatko Andonovski, Andries Jonker, Lieke Martens, Victoria Pelova, Alyssa Naeher, Trinity Rodman, Van Domselaar, Dominique Janssen, Striker Morgan, Ertz, Brugts's, Rodman, Sophia Smith, Martens, Amy Tennery, Nick Mulvenney Organizations: Soccer Football, FIFA, Wellington Regional, Danielle van de Donk REUTERS, Dutch, Portugal, U.S, Thomson Locations: New Zealand, States, Netherlands, Wellington , New Zealand, WELLINGTON, United States, U.S, Vietnam, Dutch, Wellington

July 18 (Reuters) - Johnson & Johnson (JNJ.N) sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance plan the power to negotiate lower drug prices. The pharmaceutical industry says the drug price negotiation program under President Joe Biden's signature Inflation Reduction Act law will curtail profits and compel drugmakers to curb development of groundbreaking new treatments. The U.S. Centers for Medicare and Medicaid Services (CMS) in September is expected to select the first 10 drugs to target for negotiations with settled prices set to take effect in 2026. The law is on our side," a spokesperson for the U.S. Department of Health and Human Services said in a statement. It broadly follows the other related lawsuits, arguing that the program is unconstitutional and amounts to "confiscation of constitutionally protected property."

Persons: Johnson, Joe Biden's, drugmakers, Biden, Janssen, Bhanvi, Michael Erman, Krishna Chandra Eluri, Susan Heavey Organizations: Johnson, U.S, drugmakers Bristol Myers Squibb, Merck & Co, U.S . Chamber of Commerce, Pharmaceutical Research, Manufacturers of America, Commerce, U.S . Centers, Medicare, Medicaid Services, U.S . Department of Health, Human Services, District of, Thomson Locations: U.S, District of New Jersey, Bengaluru, New Jersey

Overall, an FDA spokesperson says that “trial participants should reflect the population that is likely to use the product if FDA-approved. Across a group of 10 novel cancer therapies approved by the FDA in 2022, data shows the share of Black participants in key clinical trials ranged from zero to 8%. “Access to clinical trials at the sites where patients are living is an important factor to changing the landscape,” Perez says. “There’s been some novel ways to recruit patients, like using the church and using barbershops to recruit Black patients,” Cho says. Haddad says a number of Mayo patients were receiving experimental therapies through clinical trials when the pandemic began.

Persons: ”, Leslie Cho, Robert, Suzanne Tomsich, it’s, Edith Perez, Bolt Biotherapeutics, ” Perez, Eli Lilly, “, Lilly “, they’ll, Craig Lipset, ” Lipset, ” Cho, “ There’s, Dr, Tufia Haddad, Haddad, Mayo, Jennifer Dahne, Larry Hawk, Hawk Organizations: Women’s Cardiovascular, Cleveland Clinic, of Cardiovascular Medicine, U.S . Food, Drug Administration, FDA, “, Health, Committee, Cancer, Janssen Pharmaceuticals, Centers for Disease Control, Research Alliance, Mayo Clinic Comprehensive Cancer Center, Care, Mayo’s Center for Digital Health, College of Medicine, Medical University of South, of Psychology, University, Buffalo, SUNY, JAMA Locations: U.S, Chicago, Dallas, Los Angeles, Philadelphia, Los Angeles County, Alaska, “, Medical University of South Carolina

☆ Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
▼ + stars: | 2023-06-20 | by ( Spencer Kimball | ) www.cnbc.com time to read: +10 min

And Bristol Myers Squibb is trying protect its blood thinner Eliquis, which brought in $11.8 billion in sales last year, or about 25% of the company's $46 billion total revenue for 2022. Long legal battle aheadMerck, the chamber and Bristol Myers Squibb filed their lawsuits ahead of two key deadlines. Bristol Myers Squibb did not either. If circuit court decisions on the matter contradict one another, the Supreme Court would step in to decide the issue, Bagby said. Bristol Myers Squibb made an identical argument in its complaint.

Persons: Richard A, Gonzalez, Pascal Soriot, Giovanni Caforio, Jennifer Taubert, Johnson, Kenneth C, Frazier, Albert Bourla, Olivier Brandicourt, Win Mcnamee, Drugmaker Merck, Drugmaker, Bristol Myers Squibb, PhRMA, Eli Lilly, Merck, Bristol Myers, Robin Feldman, Nicholas Bagley, Bagley, Gretchen Whitmer, Chris Meekins, Raymond James, Antonin Scalia, Brett Kavanaugh, Neil Gorsuch, Meekins, Long, Xavier Becerra, Randolph Daniel Moss, Barack Obama, Judge Thomas M, Rose, George W, Bush, Kelly Bagby, Bagby, Amgen, Donald Trump, Karine Jean, Pierre, Biden, Jean, we'll, Becerra, Feldman Organizations: Senate, AbbVie Inc, AstraZeneca, Myers Squibb Co, Janssen Pharmaceuticals, Johnson, Merck & Co, Inc, Pfizer, Sanofi, Getty, U.S . Chamber of Commerce, Bristol Myers Squibb, Washington , D.C, Southern, Southern District of, Democratic Party, U.S, Merck, Bristol, Pharmaceutical Research, Manufacturers of America, CNBC, Medicare, University of California College of, Justice Department, Michigan Gov, Bristol Myers, Human Services, Centers, Services, AARP Foundation, HHS, AARP, Specialty Pharmacy, Reuters, Supreme, Appeals, Democratic, U.S . Sixth, Republican, Third, White Locations: America, Washington , DC, Bristol, U.S, Washington ,, Southern District, Southern District of Ohio, New Jersey, Commerce's Dayton , Ohio, San Francisco

☆ GOP law cut Big Pharma tax rates by 40%, Senate report says
▼ + stars: | 2023-05-11 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

A Republican law has slashed the average tax rates of big pharmaceutical companies by more than 40% since it was enacted in 2017, Senate Finance Committee Democrats said in a report Thursday. That provision allowed U.S.-based pharmaceutical companies to access lower tax rates on their foreign income, the report said. Pharmaceutical companies report 75% of their taxable income overseas, the report said. The report said the average rate fell to 11.6% in 2019 and 2020, which resulted in billions of dollars in tax savings for pharmaceutical companies. Wyden also obtained similar information about other U.S. pharmaceutical companies, including Abbott Laboratories , Amgen , Bristol Myers Squibb and Merck .

☆ CDC eases certain Covid-19 vaccine requirements for international travelers to US
▼ + stars: | 2023-04-28 | by ( Brenda Goodman | ) edition.cnn.com time to read: +2 min

CNN —The US Centers for Disease Control and Prevention is still requiring international visitors boarding flights to the United States to be vaccinated against Covid-19, but it’s easing vaccine requirements for those travelers. International travelers boarding flights to the United States will now be considered fully vaccinated two weeks after getting a single dose of either the Pfizer or Moderna mRNA vaccine any time after August 16, 2022, when bivalent formulations first became available. Previously, foreign travelers entering the United States were considered fully vaccinated two weeks after the second dose of a vaccine that required two primary doses, or two weeks after a vaccine that only required a single shot, such as the Johnson & Johnson vaccine. A number of older, monovalent vaccine regimens also qualify a foreign visitor as fully vaccinated. As part of the update, the older monovalent mRNA Covid-19 vaccines are no longer recommended in the United States, and updated vaccines are recommended for everyone age 6 months and older.

Search resuls for: "Janssen"

25 mentions found